Vitamin D: A custodian of cell signalling stability in health and disease

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 349-358

  Berridge, Michael J ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Alzheimer's diseases; Antioxidants; Calcium; Cardiac disease; Klotho; Memory; Phenotypic stability; Reactive oxygen species; Redox; Vitamin D

Indexed keywords

CALCIUM ION; REACTIVE OXYGEN METABOLITE; VITAMIN D; BETA GLUCURONIDASE; KLOTHO PROTEIN; NFE2L2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR NRF2;

AGING; ALZHEIMER DISEASE; CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; EPIGENETICS; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INTRACELLULAR SIGNALING; METASTASIS; MOLECULAR STABILITY; NEOPLASM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK REDUCTION; SCHIZOPHRENIA; VITAMIN D DEFICIENCY; GENETICS; METABOLISM; MULTIPLE SCLEROSIS; PATHOLOGY;

ALZHEIMER DISEASE; CALCIUM SIGNALING; CARDIOVASCULAR DISEASES; GLUCURONIDASE; HUMANS; MULTIPLE SCLEROSIS; NF-E2-RELATED FACTOR 2; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES; VITAMIN D;

EID: 84934892658     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140279     Document Type: Review

References (105)

1. Berridge, M.J., Lipp, P. and Bootman, M.D. (2000) The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11-21 CrossRef PubMed
2. Berridge, M.J. (2012) Calcium signalling remodelling and disease. Biochem. Soc.Trans. 40, 297-309 CrossRef PubMed
3. Berridge, M.J., Bootman, M.D. and Roderick, H.L. (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517-529 CrossRef PubMed
4. Grant, W.R. (2009) The health benefits of solar irradiance and Vitamin D and the consequences of their deprivation. Clin. Rev. Bone. Miner. Metab. 7, 134-146 CrossRef
5. Harms, L.R., Burne, T.H.J., Eyles, D.W. and McGrath, J.J. (2011) Vitamin D and the brain. Best Pract. Res. Clin. Endocrinol. Metab. 25, 657-669 CrossRef PubMed
6. Hossein-nezhad, A. and Holick, M.F. (2013) Vitamin D for health: a global perspective. Mayo Clin. Proc. 88, 720-755 CrossRef PubMed
7. Wang, Y. and Sun, Z. (2009) Current understanding of klotho. Ageing Res. Rev. 8, 43-51 CrossRef PubMed
8. Zeldich, E., Chen, C.-D., Colvin, T.A., Bove-Fenderson, E.A., Liang, J., Zhou, T.B., Harris, D.A. and Abraham, C.R. (2014) The neuroprotective effect of Klotho is mediated via regulation of members of the redox system. J. Biol. Chem. 289, 24700-24715 CrossRef PubMed
9. Yamamoto, M., Clark, J.D., Pastor, J.V., Gurnani, P., Nandi, A., Kurosu, H., Miyoshi, M., Ogawa, Y., Castrillon, D.H., Rosenblatt, K.P. and Kuro-o, M. (2005) Regulation of oxidative stress by the anti-aging hormone klotho. J. Biol. Chem. 280, 38029-38034 CrossRef PubMed
10. Chen, C.D., Sloane, J.A., Li, H., Aytan, N., Giannaris, E.L., Zeldich, E., Hinman, J.D., Dedeoglu, A., Rosene, D.L., Bansal, R. et al. (2013) The antiaging protein klotho enhances oligodendrocyte maturation and myelination of the CNS. J. Neurosci. 33, 1927-1939 CrossRef PubMed
11. Hayes, J.D. and Dinkova-Kostova, A.T. (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39, 199-218 CrossRef PubMed
12. Magesh, S., Chen, Y. and Hu, L. (2012) Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med. Res. Rev. 32, 687-726 CrossRef PubMed
13. Finkel, T. (2011) Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7-15 CrossRef PubMed
14. Hidalgo, C. and Donoso, P. (2008) Crosstalk between calcium and redox signaling: from molecular mechanisms to health implications. Antioxid. Redox. Signal. 10, 1275-1312 CrossRef PubMed
15. Bootman, M.D., Taylor, C.W. and Berridge, M.J. (1992) The thiol reagent, thimerosal, evokes Ca2+ spikes in HeLa cells by sensitizing the inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 267, 25113-25119 PubMed
16. Lock, J.T., Sinkins, W.G. and Schilling, W.P. (2012) Protein S-glutathionylation enhances Ca2+-induced Ca2+ release via the IP3 receptor in cultured aortic endothelial cells. J. Physiol. 590, 3431-3447 CrossRef PubMed
17. Prosser, B.L., Khairallah, R.J., Ziman, A.P., Ward, C.W. and Lederer, W.J. (2013) X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates [Ca2+]i. J. Mol. Cell Cardiol. 58, 172-181 CrossRef PubMed
18. Evangelista, A.M., Thompson, M.D., Weisbrod, R.M., Pimental, D.R., Tong, X., Bolotina, V.M. and Cohen, R.A. (2012) Redox regulation of SERCA2 is required for vascular endothelial growth factor-induced signaling and endothelial cell migration. Antioxid. Redox Signal. 17, 1099-1108 CrossRef PubMed
19. Dong, J.H., Wong, S.L., Lau, C.W., Lee, H.K., Ng, C.F., Zhang, L.H., Yao, X.Q., Chen, Z.Y., Vanhoutte, P.M. and Huang, Y. (2012) Calcitriol protects renovascular function in hypertension by downregulating angiotensin II type 1 receptors and reducing oxidative stress. Eur. Heart. J. 33, 2980-2990 CrossRef PubMed
20. Briones, T.L. and Darwish, H. (2014) Decrease in age-related tau hyperphosphorylation and cognitive improvement following vitamin D supplementation are associated with modulation of brain energy metabolism and redox state. Neuroscience 262, 143-155 CrossRef PubMed
21. Bao, B-Y., Ting, H-J., Hsu, J-W. and Lee, Y-F. (2008) Protective role of 1a, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells. Int. J. Cancer 122, 2699-2706 CrossRef PubMed
22. de Viragh, P.A., Haglid, K.G. and Celio, M.R. (1980) Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc. Natl. Acad. Sci. U.S.A. 86, 3887-3890 CrossRef
23. Perez, A.V., Picotto, G., Carpentieri, A.R., Rivoira, M.A., Peralta Lopez, M.E. and Tolosa de Talamoni, N.G. (2008) Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway. Digestion 77, 22-34 CrossRef PubMed
24. Imura, A., Tsuji, Y., Murata, M., Maeda, R., Kubota, K., Iwano, A., Obuse, C., Togashi, K., Tominaga, M., Kita, N. et al. (2007) alpha-Klotho as a regulator of calcium homeostasis. Science 316, 1615-1618 CrossRef PubMed
25. Brewer, L.D., Thibault, V., Chen, K.C., Langub, M.C., Landfield, P.W. and Porter, N.M. (2001) Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type Ca2+ channel expression in hippocampal neurons. J. Neurosci. 21, 98-108 PubMed
26. Fetahu, I.S., Höbaus, J. and Kállay, E. (2014) Vitamin D and the epigenome. Front. Physiol. 5, 164 CrossRef PubMed
27. Kao, Y.H., Cheng, C.C., Chen, Y.C., Chung, C.C., Lee, T.I., Chen, S.A. and Chen, Y.J. (2011) Hydralazine-induced promoter demethylation enhances sarcoplasmic reticulum Ca2+ -ATPase and calcium homeostasis in cardiac myocytes. Lab. Invest. 91, 1291-1297 CrossRef PubMed
28. King, G.D., Rosene, D.L. and Abraham, C.R. (2011) Promoter methylation and age-related downregulation of klotho in rhesus monkey. Age 34, 1405-1419 CrossRef PubMed
29. van Otterdijk, S.D., Mathers, J.C. and Strathdee, G. (2013) Do age-related changes in DNA methylation play a role in the development of age-related diseases? Biochem. Soc. Trans. 41, 803-807 CrossRef PubMed
30. Guidotti, A., Auta, J., Chen, Y., Davis, J.M., Dong, E., Gavin, D.P., Grayson, D.R., Matrisciano, F., Pinna, G., Satta, R. et al. (2011) Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60, 1007-1016 CrossRef PubMed
31. Pereira, F., Barbáchano, A., Singh, P.K., Campbell, M.J., Muñoz, A. and Larriba, M.J. (2012) Vitamin D has wide regulatory effects on histone demethylase genes. Cell Cycle 11, 1081-1089 CrossRef PubMed
32. Khachaturian, Z.S. (1987) Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol. Aging 8, 345-346 CrossRef PubMed
33. Landfield, P.W. (1987) 'Increased calcium-current' hypothesis of brain aging. Neurobiol. Aging 8, 346-347 CrossRef PubMed
34. Foster, T.C. (2007) Calcium homeostasis and modulation of synaptic plasticity in the aged brain. Aging Cell 6, 319-325 CrossRef PubMed
35. Bodhinathan, K., Kumar, A. and Foster, T.C. (2010) Redox sensitive calcium stores underlie enhanced after hyperpolarization of aged neurons: role for ryanodine receptor mediated calcium signaling. J. Neurophysiol. 104, 2586-2593 CrossRef PubMed
36. Zaidi, A., Gao, J., Squier, T.C. and Michaelis, M.L. (1998) Age-related decrease in brain synaptic membrane Ca2+-ATPase in F344/BNF1 rats. Neurobiol. Aging 19, 487-495 CrossRef PubMed
37. Brewer, L.D., Porter, N.M., Kerr, D.S., Landfield, P.W. and Thibault, O. (2006) Chronic 1alpha,25-(OH)2 vitamin D3 treatment reduces Ca2+-mediated hippocampal biomarkers of aging. Cell Calcium 40, 277-286 CrossRef PubMed
38. Latimer, C.M., Brewer, L.D., Searcy, J.L., Chen, K-C., Popovic, J., Kraner, S.D., Thibault, O., Blalock, E.M., Landfield, P.W. and Porter, N.M. (2014) Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc. Natl. Acad. Sci. U.S.A. 111, E4359-E4366
39. Deeb, K.K., Trump, D.L. and Johnson, C.S. (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer. 7, 684-700 CrossRef PubMed
40. Gorham, A.E., Mohr, S.B., Garland, F.C. and Garland, C.F. (2009) Vitamin D for cancer prevention and survival. Clin. Rev. Bone Miner. Metab. 7, 159-175 CrossRef
41. Feldman, D., Krishnan, A.V., Swami, S., Giovannucci, E. and Feldman, B.J. (2014) The role of vitamin D in reducing cancer risk and progression. Nat. Rev. Cancer 14, 342-357 CrossRef PubMed
42. Jensen, S.S., Madsen, W.S., Lukas, J., Binderup, L. and Bartek, J. (2001) Inhibitory effects of 1a,25-dihydroxyvitamin D3 on the G1-S phase-controlling machinery. Mol. Endocrinol. 15, 1370-1380 PubMed
43. Jiang, F., Li, P., Fornace, Jr, A.J., Nicosia, S.V. and Bai, W. (2003) G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J. Biol. Chem. 278, 48030-48040 CrossRef PubMed
44. Reuter, S., Gupta, S.C., Chaturvedi, M.M. and Aggarwal, B.B. (2010) Oxidative stress, inflammation and cancer: how are they linked. Free Radic. Biol. Med. 49, 1603-1616 CrossRef PubMed
45. Cheung, K.L., Lee, J.H., Khor, T.O., Wu, T.Y., Li, G.X., Chan, J., Yang, C.S. and Kong, A.N. (2014) Nrf2 knockout enhances intestinal tumorigenesis in Apc(min/+) mice due to attenuation of anti-oxidative stress pathway while potentiates inflammation. Mol. Carcinog. 53, 77-84 CrossRef PubMed
46. Prevarskaya, N., Ouadid-Ahidouch, H., Skryma, R. and Shuba, Y. (2014) Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks? Philos. Trans. R. Soc. Lond. B Biol. Sci. 369, 20130097 CrossRef
47. Stubbins, R.E., Hakeem, A. and Nunez, N.P. (2012) Using components of the vitamin D pathway to prevent/treat colon cancer. Nutr. Rev. 70, 721-729 CrossRef PubMed
48. Aguilera, O., Peña, C., Garcia, J., Larríba, M., Ordóñez-Morán, P., Navarro, D., Barbáchano, A., López de Silanes, I., Ballestar, E., Fraga, M.F. et al. (2007) The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 28, 1877-84 CrossRef PubMed
49. Pálmer, H., González-Sancho, J., Espada, J., Berciano, M., Puig, I., Baulida, J., Quintanill, A.M., Cano, A., de Herreros, A.G., Lafarga, M. and Munoz, A. (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J. Cell Biol. 154, 369-387 CrossRef PubMed
50. Padi, S.K., Zhang, Q., Rustum, Y.M., Morrison, C. and Guo, B. (2013) MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. Gastroenterology 145, 437-446 CrossRef PubMed
51. Chen, B., Zhang, Y., Wang, Y., Rao, J., Jiang, X. and Xu, Z. (2014) Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression. J. Steroid. Biochem. Mol. Biol. 143, 11-18 CrossRef PubMed
52. Mantell, D.J., Owens, P.E., Bundred, N.J., Mawer, E.B. and Canfield, A.E. (2000) 1α,25- dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo. Circ. Res. 87, 214-220 CrossRef PubMed
53. Nakagawa, K., Kawaura, A., Kato, S., Takeda, E. and Okano, T. (2005) 1α,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis 26, 429-440 CrossRef PubMed
54. Sherman, M.H., Yu, R.T., Engle, D.D., Ding, N., Atkins, A.R., Tiriac, H., Collisson, E.A., Connor, F., Van Dyke, T., Kozlov, S. et al. (2014) Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell 159, 80-93 CrossRef PubMed
55. DeLuca, G.C., Kimball, S.M., Kolasinski, J., Ramagopalan, S.V. and Ebers, G.C. (2013) Review: the role of vitamin D in nervous system health and disease. Neuropathol. Appl. Neurobiol. 39, 458-484 CrossRef PubMed
56. Wang, L., Hara, K., Van Baaren, J.M., Price, J.C., Beecham, G.W., Gallins, P.J., Whitehead, P.L., Wang, G., Lu, C., Slifer, M.A. et al. (2012) Vitamin D receptor and Alzheimer's disease: a genetic and functional study. Neurobiol. Aging 33, 1844.e1-1844.e9
57. Lehmann, D.J., Refsum, H., Warden, D.R., Medway, C., Wilcock, G.K. and Smith, A.D. (2011) The vitamin D receptor gene is associated with Alzheimer's disease. Neurosci. Lett. 504, 79-82 CrossRef PubMed
58. Gezen-Ak, D., Yilmazer, S. and Dursun, E. (2014) Why vitamin D in Alzheimer's disease? The hypothesis. J. Alzheimers Dis. 40, 257-269 PubMed
59. Annweiler, C., Rolland, Y., Schott, A.M., Blain, H., Vellas, B., Herrmann, F.R. and Beauchet, O. (2012) Higher vitamin D dietary intake is associated with lower risk of Alzheimer's disease: a 7-year follow-up. J. Gerontol. A Biol. Sci. Med. Sci. 67, 1205-1211 CrossRef PubMed
60. Geula, C., Bu, J., Nagykery, N., Scinto, L.F.M., Chan, J., Joseph, J., Parker, R. and Wu, C.K. (2003) Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss. J. Comp. Neurol. 455, 249-259 CrossRef PubMed
61. Palop, J.J., Jones, B., Kekonius, L., Chin, J., Yu, G.-Q., Raber, J., Masliah, E. and Mucke, L. (2003) Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc. Natl. Acad. Sci. U.S.A. 100, 9572-9577 CrossRef PubMed
62. LaFerla, F.M. (2002) Calcium dyshomeostasis and intracellular signaling in Alzheimer's disease. Nat. Rev. Neurosci. 3, 862-872 CrossRef PubMed
63. Bezprozvanny, I. and Mattson, M.P. (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 31, 454-463 CrossRef PubMed
64. Stutzmann, G.E. and Mattson, M.P. (2011) Endoplasmic reticulum Ca2+ handling in cells in health and disease. Pharmacol. Rev. 63, 700-727 CrossRef PubMed
65. Um, J.W., Kaufman, A.C., Kostylev, M., Heiss, J.K., Stagi, M., Takahashi, H., Kerrisk, M.E., Vortmeyer, A., Wisniewski, T., Koleske, A.J. et al. (2013) Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron 79, 887-902 CrossRef PubMed
66. Sayre, L.M., Smith, M.A. and Perry, G. (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8, 721-738 CrossRef PubMed
67. Texel, S.J. and Mattson, M.P. (2011) Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease. Antioxid. Redox Signal. 14, 1519-1534 CrossRef PubMed
68. Butterfield, D.A., Swomley, A.M. and Sultana, R. (2013) Amyloid β-peptide (1-42)-Induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid. Redox Signal. 19, 823-835 CrossRef PubMed
69. Ghosh, D., Levault, K.R. and Brewer, G.J. (2014) Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons. Aging Cell 13, 631-640 CrossRef PubMed
70. Berridge, M.J. (2014) Calcium regulation of neural rhythms, memory and Alzheimer's disease. J. Physiol. 592, 281-293 CrossRef PubMed
71. Nagai, T., Yamada, K., Kim, H.C., Kim, Y.S., Noda, Y., Imura, A., Nabeshima, Y. and Nabeshima, T. (2003) Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J. 17, 50-52 PubMed
72. Dubal, D.B., Yokoyama, J.S., Zhu, L., Broestl, L., Worden, K., Wang, D., Sturm, V.E., Kim, D., Klein, E., Yu, G.Q. et al. (2014) Life extension factor klotho enhances cognition. Cell Rep. 22, 1065-1076 CrossRef
73. Rong, Y.P. and Distelhorst, C.W. (2008) Bcl-2 protein family: versatile regulators of calcium signaling in cell survival and apoptosis. Annu. Rev. Physiol. 70, 73-91 CrossRef PubMed
74. Berridge, M.J. (2012) Dysregulation of neural calcium signalling in Alzheimer disease, bipolar disorder and schizophrenia. Prion 6, 1-12 PubMed
75. Uhlhaas, P.J. and Singer, W. (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat. Rev. Neurosci. 11, 100-113 CrossRef PubMed
76. Gonzalez-Burgos, G. and Lewis, D.A. (2012) NMDA receptor hypofunction,parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr. Bull. 38, 950-957 CrossRef PubMed
77. Najjar, S., Pearlman, D.M., Alper, K., Najjar, A. and Devinsky, O. (2013) Neuroinflammation and psychiatric illness. J. Neuroinflammation 10, 43-67 CrossRef PubMed
78. Snyder, M.A. and Gao, W.-J. (2013) NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia. Front. Cell Neurosci. 7, 1-12 CrossRef PubMed
79. Behrens, M.M. and Sejnowski, T.J. (2009) Does schizophrenia arise from oxidativdysregulation of parvalbumin-interneurons in the developing cortex? Neuropharmacology 57, 193-200 CrossRef PubMed
80. Kesby, J.P., Cui, X.Y., O'Loan, J., McGrath, J.J., Burne, T.H. and Eyles, D.W. (2010) Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats. Psychopharmacology 208, 159-168 CrossRef PubMed
81. Dean, O.M., van den Buuse, M., Bush, A.I., Copolov, D.L., Ng, F., Dodd, S. and Berk, M. (2009) A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr. Med. Chem. 16, 2965-2976 CrossRef PubMed
82. Berridge, M.J. (2014) Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia. Cell Tissue Res. 357, 477-492 CrossRef PubMed
83. Berk, M., Malhi, G.S., Gray, L.J. and Dean, O.M. (2013) The promise of N-acetylcysteine in neuropsychiatry. Trend Pharm. Sci. 34, 167-177 CrossRef
84. Butler, M.W., Burt, A., Edwards, T.L., Zuchner, S., Scott, W.K., Martin, E.R., Vance, J.M. and Wang, L. (2011) Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann. Hum. Genet. 75, 201-210 CrossRef PubMed
85. Surmeier, D.J. and Schumacker, P.T. (2013) Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease. J. Biol. Chem. 288, 10736-10741 CrossRef PubMed
86. Zhou, C., Lu, F., Cao, K., Xu, D., Goltzman, D. and Miao, D. (2008) Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 74, 170-179 CrossRef PubMed
87. Nasri, H., Behradmanesh, S., Ahmadi, A. and Rafieian-Kopaei, M. (2014) Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized, double-blind, placebo controlled clinical trial. J. Nephropathol. 3, 29-33 PubMed
88. Yuan, W., Pan, W., Kong, J., Zheng, W., Szeto, F.L., Wong, K.E., Cohen, R., Klopot, A., Zhang, Z. and Li, Y.C. (2007) 1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J. Biol. Chem. 282, 29821-29830 CrossRef PubMed
89. Fukino, K., Suzuki, T., Saito, Y., Shindo, T., Amaki, T., Kurabayashi, M. and Nagai, R. (2002) Regulation of angiogenesis by the aging suppressor gene klotho. Biochem. Biophys. Res. Commun. 293, 332-337 CrossRef PubMed
90. Berridge, M.J. (2006) Remodelling Ca2+ signalling systems and cardiac hypertrophy. Biochem. Soc. Trans. 34, 228-231 CrossRef PubMed
91. Wu, X., Zhang, T., Bossuyt, J., Li, X., McKinsey, T.A., Dedman, J.R., Olson, E.N., Chen, J., Brown, J.H. and Bers, D.M. (2006) Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J. Clin. Invest. 116, 675-682 CrossRef PubMed
92. Molkentin, J.D. (2006) Dichotomy of Ca2+ in the heart: contraction versus intracellular signaling. J. Clin. Invest. 116, 623-626 CrossRef PubMed
93. Luo, D., Yang, D., Lan, X., Li, K., Li, X., Chen, J., Zhang, Y., Xiao, R.P., Han, Q. and Cheng, H. (2008) Nuclear Ca2+ sparks and waves mediated by inositol 1,4,5-trisphosphate receptors in neonatal rat cardiomyocytes. Cell Calcium 43, 165-174 CrossRef PubMed
94. Harzheim, D., Movassagh, M., Foo, R.S., Ritter, O., Tashfeen, A., Conway, S.J., Bootman, M.D. and Roderick, H.L. (2009) Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+transients and arrhythmias associated with cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 106, 11406-11411 CrossRef PubMed
95. Higazi, D.R., Fearnley, C.J., Drawnel, F.M., Talasila, A., Corps, E.M., Ritter, O., McDonald, F., Mikoshiba, K., Bootman, M.D. and Roderick, H.L. (2009) Endothelin-1-stimulated InsP3-induced Ca2+ release is a nexus for hypertrophic signalling in cardiac myocytes. Mol. Cell 33, 472-482 CrossRef PubMed
96. Nakayama, H., Bodi, I., Maillet, M., DeSantiago, J., Domeier, T.L., Mikoshiba, K., Lorenz, J.N., Blatter, L.A., Bers, D.M. and Molkentin, J.D. (2010) The IP3 receptor regulates cardiac hypertrophy in response to select stimuli. Circ. Res. 107, 659-666 CrossRef PubMed
97. Sag, C.M., Santos, C.X. and Shah, A.M. (2014) Redox regulation of cardiac hypertrophy. J. Mol. Cell Cardiol. 73, 103-111 CrossRef PubMed
98. Köhler, A.C., Sag, C.M. and Maier, L.S. (2014) Reactive oxygen species and excitation-contraction coupling in the context of cardiac pathology. J. Mol. Cell Cardiol. 73, 92-102 CrossRef PubMed
99. Bendall, J.K., Cave, A.C., Heymes, C., Gall, N. and Shah, A.M. (2002) Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105, 293-296 CrossRef PubMed
100. Gotsman, I., Shauer, A., Zwas, D.R., Hellman, Y., Keren, A., Lotan, C. and Admon, D. (2012) Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur. J. Heart Fail. 14, 357-366 CrossRef PubMed
101. Hanafy, D.A., Chang, S.L., Lu, Y.Y., Chen, Y.C., Kao, Y.H., Huang, J.H., Chen, S.A. and Chen, Y.J. (2014) Electromechanical effects of 1,25-dihydroxyvitamin D with antiatrial fibrillation activities. J. Cardiovasc. Electrophysiol. 25, 317-323 CrossRef PubMed
102. MacKenzie, L., Bootman, M.D., Laine, M., Brig, J., Thuring, J., Holmes, A., Li, W.-H. and Lipp, P. (2002) The role of inositol 1,4,5-trisphosphate receptors in Ca2+ signalling and the generation of arrhythmias in rat atrial myocytes. J. Physiol. 541, 395-409 CrossRef PubMed
103. Mackenzie, L., Roderick, H.L., Berridge, M.J., Conway, S.J. and Bootman, M.D. (2004) The spatial pattern of atrial cardiomyocyte calcium signalling modulates contraction. J. Cell Sci. 117, 6327-6337 CrossRef PubMed
104. Kockskämper, J., Zima, A.V., Roderick, H.L., Pieske, B., Blatter, L.A. and Bootman, M.D. (2008) Emerging roles of inositol 1,4,5-trisphosphate signalling in cardiac myocytes. J. Mol. Cell. Cardiol. 45, 128-147 CrossRef PubMed
105. Proven, A., Roderick, H.L., Conway, S.J., Berridge, M.J., Horton, J.K., Capper, S.J. and Bootman, M.D. (2006) Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes. J. Cell Sci. 119, 3363-3375 CrossRef PubMed